An interdisciplinary field which includes the application of
engineering principles to biology is known as synthetic biology. Relatively new
as compared to other disciplines of Science and Technology, its main objective
is to (re-)design and fabricates such biological components and systems which
do not already present in the natural world. To ensure speedy manufacture of
modified DNA sequences, and their assembly into two genomes, researchers integrate
a chemical synthesis of DNA with better knowledge of genomics. The rising
demand for synthetic biology from Biotechnological and Pharmaceutical companies
for research and development purposes which contributes to the growth of the synthetic
biology market. The application of synthetic biology methods in drug
discovery and development also acts as a growth driver for the global synthetic
biology market. Furthermore, the investments made by the governments and several
corporate organizations in the science and technology field for the discovery
of drugs and synthetic biological products, specifically for the development of
successful vaccinations to COVID-19 are offering to be a key driver for the
growth of synthetic biology market. Moreover, the increasing demand for bio-fuel
as a result of global energy crisis, exhaustion of fossil fuels and rising pollution
will further favor the synthetic biology market growth. Latest advancements in
synthetic biology are paving the way for fourth-generation bio-fuels
production, where particularly engineered microorganism/crops will act as
feedstock material. Increased per capita energy consumption across the world
due to the rapid industrialization with an increase in global population is projected
to propel synthetic biology applications across energy sector. However, the dearth of predictability in
biology which eventually results in a risk of failure of research and
experiments may hamper market growth.
In addition, the rising concern associated to food security
with increasing population, changing climate and environmental stress will also
fuel the market demand. The major focus of synthetic biology is to fulfill
sustainable agricultural practices which allow minimum use of chemical
fertilizers and pesticides coupled with increased yield. Factors such as food
production with improved shelf life, higher and customized nutritional or
medicinal value will boost synthetic biology applications across food and
agricultural sector. Increasing use of artificial intelligence, machine
learning, and big data for clinical research on bio-systems modeling, chassis
development, and genome mining can create an opportunity for the growth of the synthetic
biology market in the forecast period.
The
global Synthetic Biology Market is segregated on the basis of Products as Synthetic
DNA, Synthetic Oligos, Synthetic Genes, Software Tools, Chassis Organisms, Synthetic
Clones and Synthetic Cells. Based on Technology the global Synthetic Biology
Market is segmented in Nucleotide Synthesis & Sequencing, Bioinformatics, Microfluidics
and Genetic Engineering. Based on Application the global Synthetic Biology
Market is segmented in Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplastics
and Others.
The
global Synthetic Biology Market report provides geographic analysis covering
regions, such as Europe, North America, Asia Pacific, and Rest of The World.
The Synthetic Biology Market for each region is further segmented for major
countries including the U.S., Canada, Germany, the U.K., France, Italy, China,
India, Japan, Brazil, South Africa, and others.
Competitive Analysis
Agilent
Technologies, Creative Enzymes, Cyrus Biotechnology, Eurofins Scientific and Integrated
DNA Technologies and others are among the major players in the global Synthetic
Biology Market. The companies studied in terms of product strategy and various
n several growth and expansion strategies to gain a competitive edge in the
market. The major players not only follow value chain integration with business
operations in multiple stages of the value chain.
- In March
2020, Zymergen Inc., a California based material innovation company, acquiring
enEvolv, Inc. This acquisition has resulted in Zymergen accelerating its
delivery of high performing, sustainable products to its customers, besides
further bonding the Zymergen’s leadership position in the bio-manufacturing
space.
- In 2019,
Thermo Fisher Scientific Inc., the world leading company in serving science,
officially inaugurated its new $90 million viral vector CDMO (contract
development and manufacturing organization) site in Lexington, Mass. The
50,000-square-foot facility will include more than 200 jobs and help the
development, testing and manufacture of viral vectors, which are vital to
advancing new life-saving gene and cell therapies worldwide.
- In
February 2021, Merck collaborated with BioNTech (Germany) to provide lipids for
the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
The global Synthetic Biology Market has been
segmented as below:
Synthetic
Biology Market, By Products
- Synthetic DNA
- Synthetic Oligos
- Synthetic Genes
- Software Tools
- Chassis Organisms
- Synthetic Clones
- Synthetic Cells
Synthetic
Biology Market, By Technology
- Nucleotide Synthesis And Sequencing
- Bioinformatics
- Microfluidics
- Genetic Engineering
Synthetic
Biology Market, By Application
- Pharmaceuticals & Diagnostics
- Chemicals
- Biofuels
- Bioplastics
- Others
Synthetic
Biology Market, By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
Synthetic
Biology Market, By Company
- Agilent Technologies
- Creative Enzymes
- Cyrus Biotechnology
- Eurofins Scientific
- Integrated DNA Technologies
- Amyris
- Arzeda
- Atum
- Codexis
- GenScript
- Ginkgo Bioworks
- Merck KGaA
- New England Biolab
- Novozymes
- Precigen
- Synthego
- Synthetic Genomics (SGI)
- Teselagen
- Thermo Fisher Scientific
- Twist Bioscience
The
report covers the below scope:
- Global Synthetic Biology Market
sizes from 2020 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2019 vs
2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to
2026
- Global Synthetic Biology Market
trends, covering comprehensive range of consumer trends & manufacturer
trends
- Value chain analysis covering
participants from raw material suppliers to the downstream buyer in the global Synthetic
Biology Market
- Major market opportunities and
challenges in forecast timeframe to be focused
- Competitive landscape with analysis
on competition pattern, portfolio comparisons, development trends and strategic
management
- Comprehensive company profiles of
the key industry players
The
years considered for the study are as follows:
- Base year - 2019
- Estimated year - 2019
- Projected year - 2020
- Forecast period - 2021 to 2026
Report
Scope:
The global Synthetic Biology Market report scope
includes detailed study covering underlying factors influencing the industry
trends. The report covers analysis on regional and country level market
dynamics. The scope also covers competitive overview providing company market
shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares
and profiles key participants in the global Synthetic Biology Market share.
Major industry players with significant revenue share include Agilent
Technologies, Creative Enzymes, Cyrus Biotechnology, Eurofins Scientific and Integrated
DNA Technologies and others.
Why to
Buy this Report:
- Gain detailed insights on the Synthetic Biology
industry trends
- Find complete analysis on the
market status
- Identify the Synthetic Biology
Market opportunities and growth segments
- Analyse competitive dynamics by
evaluating business segments & product portfolios
- Facilitate strategy planning and
industry dynamics to enhance decision making
Target
Audience:
- The report targeted towards the existing players in
the industry is as follows:
- Market Manufacturers/Service
Providers
- Market Wholesale/Traders
- Investment and Financial
Institutions
Free
and Paid Customization based on the requirement